DK1292673T3 - Trombomodulinanaloger til farmaceutisk anvendelse - Google Patents

Trombomodulinanaloger til farmaceutisk anvendelse

Info

Publication number
DK1292673T3
DK1292673T3 DK01948487T DK01948487T DK1292673T3 DK 1292673 T3 DK1292673 T3 DK 1292673T3 DK 01948487 T DK01948487 T DK 01948487T DK 01948487 T DK01948487 T DK 01948487T DK 1292673 T3 DK1292673 T3 DK 1292673T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical use
thrombomodulin
thrombin
analogs
thrombomodulin analogues
Prior art date
Application number
DK01948487T
Other languages
English (en)
Inventor
David Light
Michael John Morser
Mariko Nagashima
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Application granted granted Critical
Publication of DK1292673T3 publication Critical patent/DK1292673T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/7455—Thrombomodulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK01948487T 2000-06-21 2001-06-20 Trombomodulinanaloger til farmaceutisk anvendelse DK1292673T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21367800P 2000-06-21 2000-06-21
US09/880,484 US6632791B1 (en) 2000-06-21 2001-06-12 Thrombomodulin analogs for pharmaceutical use

Publications (1)

Publication Number Publication Date
DK1292673T3 true DK1292673T3 (da) 2006-03-27

Family

ID=26908302

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01948487T DK1292673T3 (da) 2000-06-21 2001-06-20 Trombomodulinanaloger til farmaceutisk anvendelse

Country Status (10)

Country Link
US (2) US6632791B1 (da)
EP (1) EP1292673B1 (da)
JP (1) JP4855627B2 (da)
AT (1) ATE309339T1 (da)
AU (1) AU2001269927A1 (da)
DE (1) DE60114819T2 (da)
DK (1) DK1292673T3 (da)
ES (1) ES2256266T3 (da)
NO (1) NO20026147L (da)
WO (1) WO2001098352A2 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030118580A1 (en) * 2001-11-09 2003-06-26 Rasmus Rojkjaer Pharmaceutical composition comprising factor VII polypeptides and thrombomodulin polypeptides
US7579000B2 (en) 2002-05-01 2009-08-25 Bayer Schering Pharma Ag Tissue factor targeted antibodies as anticoagulants
HK1080372A1 (zh) * 2002-05-01 2006-04-28 Schering Aktiengesellschaft 作为抗凝剂的新型组织因子目标抗体
US8012693B2 (en) 2003-12-16 2011-09-06 3M Innovative Properties Company Analysis of chemically crosslinked cellular samples
US7833978B2 (en) 2004-02-20 2010-11-16 Emory University Thrombomodulin derivatives and conjugates
EP1943332A4 (en) 2005-10-14 2011-04-13 Medimmune Inc CELLULAR DISPLAY OF ANTIBODY LIBRARIES
EP2120049A1 (de) 2008-05-14 2009-11-18 PAION Deutschland GmbH Lösliches Thrombomodulin als Biomarker bei Therapien mit Gerinnungshemmern
WO2010006635A1 (en) * 2008-07-16 2010-01-21 Paion Deutschland Gmbh Treatment of inflammatory bowel disease
US20110144024A1 (en) * 2008-07-16 2011-06-16 Paion Deutschland Gmbh Prevention and treatment of radiation injury
US20120165244A1 (en) * 2008-10-30 2012-06-28 Hua-Lin Wu Methods for binding lewis y antigen
JP2012529445A (ja) * 2009-06-12 2012-11-22 パイオン ドイチュラント ゲーエムベーハー 線溶亢進を伴う凝固障害の処置
EP2600891B1 (en) 2010-08-05 2018-01-17 Council of Scientific & Industrial Research Protein fusion constructs possessing thrombolytic and anticoagulant properties
WO2014020183A1 (de) * 2012-08-03 2014-02-06 Ici Immunochemical Intelligence Gmbh In-vitro-assay zur diagnose von störungen der hämostase
US9156904B2 (en) * 2013-07-29 2015-10-13 Blue Blood Biotech Corp. Thrombomodulin variants and use thereof
WO2017189943A1 (en) * 2016-04-28 2017-11-02 Saint Louis University Thrombin-thrombomodulin fusion proteins as a powerful anticoagulant

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466668A (en) 1989-04-28 1995-11-14 Schering Aktiengesellschaft Superior thrombomodulin analogs for pharmaceutical use
US6063763A (en) 1989-04-28 2000-05-16 Schering Aktiengesellschaft Protease-resistant thrombomodulin analogs
US5256770A (en) 1990-04-09 1993-10-26 Schering Ag Oxidation resistant thrombomodulin analogs
AU4533093A (en) * 1992-06-10 1994-01-04 Michael John Morser Mutants of the epidermal growth factor domains of human thrombomodulin

Also Published As

Publication number Publication date
EP1292673A2 (en) 2003-03-19
ES2256266T3 (es) 2006-07-16
NO20026147L (no) 2003-02-20
DE60114819T2 (de) 2006-08-10
DE60114819D1 (de) 2005-12-15
EP1292673B1 (en) 2005-11-09
AU2001269927A1 (en) 2002-01-02
NO20026147D0 (no) 2002-12-20
JP2004527452A (ja) 2004-09-09
WO2001098352A2 (en) 2001-12-27
US6632791B1 (en) 2003-10-14
US20030186883A1 (en) 2003-10-02
US6790828B2 (en) 2004-09-14
ATE309339T1 (de) 2005-11-15
WO2001098352A3 (en) 2002-08-01
JP4855627B2 (ja) 2012-01-18

Similar Documents

Publication Publication Date Title
NO20026147L (no) Trombomodulinanaloger for farmasoytisk anvendelse
TR200200768T2 (tr) Yeni kuinüklidin türevleri ve bunu içeren ilaç bileşimleri
IL232501A (en) Peptide or polypeptide-resistant protein analogs and their uses
CY1111225T1 (el) Νεα πεπτιδια ως αναστολεις πρωτεασης νs3-σερινης ιου ηπατiτιδας c
CY1112267T1 (el) Νεα πεπτιδια ως αναστολεις πρωτεασης ns3-σερινης του ιου ηπατιτιδας c
EP1594889A4 (en) NELL PEPTIDE EXPRESSION SYSTEMS AND BONE-MAKING NELL PEPTIDE ACTIVITY
NO20055863L (no) W-karboksyarylsubstituerte difenylureaforbindelser som raf-kinaseinhibitorer
DK1290011T3 (da) Melphalan-derivater og deres anvendelse som cancer-kemoterapeutiske lægemidler
EA200300937A1 (ru) Оральная фармацевтическая композиция цефподоксима проксетила
EP1505990A4 (en) METHOD FOR THE TREATMENT OF HEPATITIS
PT1268498E (pt) Fosfonatos cardioprotectores
FR2830451B1 (fr) Utilisation de peptides analogues de la thymuline(pat)pour la fabrication de medicaments contre la douleur
ATE282607T1 (de) Tryptase-inhibitoren
ATE330017T1 (de) Kallikrein gen
AU2003248535A1 (en) Heterocyclicsulfonamide hepatitis c virus inhibitors
NO20053111L (no) Peptider som inhiberer angiogenese, cellemigrering, celleinvasjon og celleproliferering.
DK0973544T3 (da) Immuntolerant prothrombinkomplekspræparat
DE502004011395D1 (de) Protein-bindende doxorubicin-peptid-derivate
IS7097A (is) Lyfjablanda til að gefa fúlvestrant í vöðva
FR2818906B1 (fr) Association medicamenteuse d'une biguanine et d'un transporteur, par exemple de metformine et d'arginine
TW200509919A (en) Cathepsin S inhibitors
ATE247130T1 (de) Inhibitoren für den urokinaserezeptor
DE60031422D1 (de) Peptidanaloge als selektive inhibitoren der thrombinaktivierung des durch protease aktivierten rezeptors
IS7200A (is) Notkun á írbesartan til framleiðslu á lækningalyfjum sem notuð eru til að koma í veg fyrir eða meðhöndla lungnaháþrýsting
UA83989C2 (ru) Выделенный пептид, который стимулирует противоопухолевый иммунный ответ, фармацевтическая композиция на его основе и ее применение